Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.21.2
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenues:        
Total revenues $ 1,506 $ 335 $ 3,675 $ 602
Operating costs and expenses:        
Research and development 1,211 867 2,941 2,469
Selling, general and administrative 3,335 819 8,226 2,060
Merger related costs 1,042 2,310 1,042
Total operating costs and expenses 5,974 3,105 16,751 6,431
Loss from operations (4,468) (2,770) (13,076) (5,829)
Other income (expense):        
Change in fair value of warrant liability 214
Change in fair value of share-settlement obligation derivative (9) (250) (220)
Loss on debt conversions   (2,518)
Other income (expense), net 4 (1) (21)
Interest income (expense), net 3 (210) (362) (247)
Total other income (expense) 7 (220) (2,937) (467)
Loss before income taxes (4,461) (2,990) (16,013) (6,296)
Income tax expense (benefit)
Net loss (4,461) (2,990) (16,013) (6,296)
Cumulative translation adjustment 17 16
Comprehensive loss $ (4,444) $ (2,990) $ (15,997) $ (6,296)
Net loss per common share:        
Net loss per share attributable to common stock - Basic and Diluted $ (0.15) $ (1.20) $ (0.78) $ (2.54)
Weighted average shares outstanding:        
Weighted average common shares outstanding - Basic and Diluted 28,986 2,500 20,466 2,476
Service [Member]        
Revenues:        
Total revenues $ 1,347 $ 238 $ 3,294 $ 414
Operating costs and expenses:        
Cost of goods sold – product 1,073 130 2,178 300
Product [Member]        
Revenues:        
Total revenues 159 97 381 188
Operating costs and expenses:        
Cost of goods sold – product $ 355 $ 247 $ 1,096 $ 560